Eleanor Barnes
Impact in
- Hepatology top 0.05%
- Hepatitis C virus research
- Infectious Diseases top 0.02%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Hepatology 149
- Hepatitis C virus research 129
-
- SARS-CoV-2 and COVID-19 Research 66
- COVID-19 Clinical Research Studies 35
- Co-authors
- Paul Klenerman (86 shared papers)Jennifer Leigh Hunt (19 shared papers)Raja R. Seethala (20 shared papers)Anthony Brown (26 shared papers)Isla Humphreys (9 shared papers)Oliver George Pybus (11 shared papers)Jonas Talmadge Johnson (11 shared papers)Eugene N. Myers (11 shared papers)
- Journals
- Journal of Hepatology (31 papers)Hepatology (22 papers)Wellcome Open Research (15 papers)Archives of Pathology & Laboratory Medicine (10 papers)Cell (9 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Eleanor Barnes
394 papers receiving 31.3k citations
Eleanor Barnes's Hit Papers
Peers
Comparison fields: 5 of 188
- Hepatology 5.9k
- Infectious Diseases 13.6k
- Health 1.9k
- Modeling and Simulation 1.1k
- Otorhinolaryngology 876
Countries citing papers authored by Eleanor Barnes
This map shows the geographic impact of Eleanor Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleanor Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleanor Barnes more than expected).
Fields of papers citing papers by Eleanor Barnes
This network shows the impact of papers produced by Eleanor Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleanor Barnes. The network helps show where Eleanor Barnes may publish in the future.
Co-authors
The 25 scholars most cited alongside Eleanor Barnes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 405 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3621 |
| 2 | Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Hit paper breakdown → | 2020 | 1899 |
| 3 | Global distribution and prevalence of hepatitis C virus genotypes Hit paper breakdown → | 2014 | 1286 |
| 4 | Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Hit paper breakdown → | 2020 | 974 |
| 5 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 867 |
| 6 | Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera Hit paper breakdown → | 2021 | 755 |
| 7 | SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses Hit paper breakdown → | 2022 | 740 |
| 8 | Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum Hit paper breakdown → | 2021 | 558 |
| 9 | Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum Hit paper breakdown → | 2022 | 547 |
| 10 | 2020 | 469 | |
| 11 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Hit paper breakdown → | 2022 | 457 |
| 12 | Antibody evasion by the P.1 strain of SARS-CoV-2 Hit paper breakdown → | 2021 | 452 |
| 13 | Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission Hit paper breakdown → | 2019 | 440 |
| 14 | MAIT cells are activated during human viral infections Hit paper breakdown → | 2016 | 424 |
| 15 | 2013 | 385 | |
| 16 | 2020 | 374 | |
| 17 | Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera Hit paper breakdown → | 2021 | 353 |
| 18 | 2012 | 349 | |
| 19 | 1986 | 326 | |
| 20 | The Extracapsular Spread of Tumors in Cervical Node Metastasis Hit paper breakdown → | 1981 | 318 |
About Eleanor Barnes
Eleanor Barnes is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Immunology and Rheumatology, having authored 405 papers that have together received 32.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (129 papers), Hepatitis B Virus Studies (80 papers), SARS-CoV-2 and COVID-19 Research (66 papers), Liver Disease Diagnosis and Treatment (57 papers), COVID-19 Clinical Research Studies (35 papers), Immune Cell Function and Interaction (32 papers), Salivary Gland Tumors Diagnosis and Treatment (30 papers) and Oral and Maxillofacial Pathology (23 papers). The work is most often cited by research in Hepatology (5.9k citations), Infectious Diseases (13.6k citations), Health (1.9k citations), Modeling and Simulation (1.1k citations) and Otorhinolaryngology (876 citations). Eleanor Barnes has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paul Klenerman, Jennifer Leigh Hunt, Raja R. Seethala, Anthony Brown, Isla Humphreys, Oliver George Pybus, Jonas Talmadge Johnson, Eugene N. Myers, Graham Cooke and Jane P. Messina. Their work appears in journals such as Journal of Hepatology, Hepatology, Wellcome Open Research, Archives of Pathology & Laboratory Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.